Indexed keywords
CETIRIZINE;
CYCLOSPORIN A;
DAPSONE;
FEXOFENADINE;
HISTAMINE H1 RECEPTOR ANTAGONIST;
IMMUNOGLOBULIN E;
KETOTIFEN;
METHOTREXATE;
MONTELUKAST;
OMALIZUMAB;
PREDNISOLONE;
RANITIDINE;
RUPATADINE;
TRYPTASE;
ADULT;
ANGIONEUROTIC EDEMA;
ARTICLE;
CASE REPORT;
CYCLING;
DISEASE DURATION;
DIZZINESS;
DRUG TREATMENT FAILURE;
ENZYME BLOOD LEVEL;
FEMALE;
HUMAN;
HYPOTENSION;
OUTCOME ASSESSMENT;
PATHOGENESIS;
PRIORITY JOURNAL;
PROVOCATION TEST;
QUALITY OF LIFE;
SKIING;
TACHYCARDIA;
TREADMILL EXERCISE;
WALKING;
ADULT;
ANGIOEDEMA;
ANTI-ALLERGIC AGENTS;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL, HUMANIZED;
FEMALE;
HISTAMINE H1 ANTAGONISTS;
HUMANS;
HYPERSENSITIVITY, IMMEDIATE;
KETOTIFEN;
TREATMENT OUTCOME;
1
70449122536
The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations
Magerl M, Borzova E, Gimenez-Arnau A, et al. The definition and diagnostic testing of physical and cholinergic urticarias-EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 2009; 64: 1715-21.
(2009)
Allergy , vol.64
, pp. 1715-1721
Magerl, M.1
Borzova, E.2
Gimenez-Arnau, A.3
2
0015399040
Vibratory angioedema: A hereditary type of physical hypersensitivity
Patterson R, Mellies CJ, Blankenship ML, et al. Vibratory angioedema: a hereditary type of physical hypersensitivity. J Allergy Clin Immunol 1972; 50: 174-82.
(1972)
J Allergy Clin Immunol , vol.50
, pp. 174-182
Patterson, R.1
Mellies, C.J.2
Blankenship, M.L.3
3
0024502609
Vibratory angioedema: Lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy
DOI 10.1111/j.1365-2133.1989.tb07770.x
Lawlor F, Black AK, Breathnach AS, et al. Vibratory angioedema. lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy. Br J Dermatol 1989; 120: 93-9. (Pubitemid 19032895)
(1989)
British Journal of Dermatology , vol.120
, Issue.1
, pp. 93-99
Lawlor, F.1
Black, A.K.2
Breathnach, A.S.3
Greaves, M.W.4
4
70349210289
EAACI/GA (2) LEN/EDF/WAO guideline: Management of urticaria
Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA (2) LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43.
(2009)
Allergy , vol.64
, pp. 1427-1443
Zuberbier, T.1
Asero, R.2
Bindslev-Jensen, C.3
5
0020580126
Nonfamilial, vibration-induced angioedema
Ting S, Reimann BE, Rauls DO, et al. Nonfamilial, vibration-induced angioedema. J Allergy Clin Immunol 1983; 71: 546-51. (Pubitemid 13061618)
(1983)
Journal of Allergy and Clinical Immunology , vol.71
, Issue.6
, pp. 546-551
Ting, S.1
Reimann, B.E.F.2
Rauls, D.O.3
Mansfield, L.E.4
6
72049102902
Efficacy of omalizumab in delayed pressure urticaria: A case report
Bindslev-Jensen C, Skov PS,. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010; 65: 138-9.
(2010)
Allergy , vol.65
, pp. 138-139
Bindslev-Jensen, C.1
Skov, P.S.2
7
77956394970
Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab
Magerl M, Staubach P, Altrichter S, et al. Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol 2010; 126: 665-6.
(2010)
J Allergy Clin Immunol , vol.126
, pp. 665-666
Magerl, M.1
Staubach, P.2
Altrichter, S.3
8
77956078962
Anti-immunoglobulin e treatment of patients with recalcitrant physical urticaria
Metz M, Altrichter S, Ardelean E, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011; 154: 177-80.
(2011)
Int Arch Allergy Immunol , vol.154
, pp. 177-180
Metz, M.1
Altrichter, S.2
Ardelean, E.3
9
77951241500
Failure of omalizumab in cholinergic urticaria
Sabroe RA,. Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol 2010; 35: e127-9.
(2010)
Clin Exp Dermatol , vol.35
Sabroe, R.A.1
